The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

被引:82
作者
Suwannasom, Pannipa [1 ,2 ,3 ]
Sotomi, Yohei [2 ]
Ishibashi, Yuki [1 ]
Cavalcante, Rafael [1 ]
Albuquerque, Felipe N. [4 ]
Macaya, Carlos [5 ]
Ormiston, John A. [6 ]
Hill, Jonathan [7 ]
Lang, Irene M. [8 ]
Egred, Mohaned [9 ]
Fajadet, Jean [10 ]
Lesiak, Maciej [11 ]
Tijssen, Jan G. [2 ]
Wykrzykowska, Joanna J. [2 ]
de Winter, Robbert J. [2 ]
Chevalier, Bernard [12 ]
Serruys, Patrick W. [13 ]
Onuma, Yoshinobu [1 ]
机构
[1] Erasmus Univ, Thoraxctr, Med Ctr, NL-3000 DR Rotterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[3] Chiang Mai Univ, Fac Med, Maharaj Nakorn Chiang Mai Hosp, Northern Reg Heart Ctr, Chiang Mai 50000, Thailand
[4] Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY USA
[5] Hosp Univ Clin San Carlos, Madrid, Spain
[6] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand
[7] Kings Coll Hosp London, London, England
[8] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria
[9] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[10] Pasteur Hosp, Dept Cardiol, Toulouse, France
[11] Med Univ Poznan, Dept Cardiol 1, Poznan, Poland
[12] Inst Jacques Cartier, Massy, France
[13] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England
关键词
asymmetry; bioresorbable vascular scaffolds; eccentricity; expansion; OPTICAL COHERENCE TOMOGRAPHY; INTRAVASCULAR-ULTRASOUND; VASCULAR SCAFFOLD; COHORT B; APPROPRIATE DEPLOYMENT; PERCUTANEOUS CORONARY; IMPLANTATION; ANGIOGRAPHY; 2ND-GENERATION; GUIDANCE;
D O I
10.1016/j.jcin.2016.03.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The study sought to investigate the relationship between post-procedural asymmetry, expansion, and eccentricity indices of metallic everolimus-eluting stent (EES) and bioresorbable vascular scaffold (BVS) and their respective impact on clinical events at 1-year follow-up. BACKGROUND Mechanical properties of a fully BVS are inherently different from those of permanent metallic stent. METHODS The ABSORB II (A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions) trial compared the BVS and metallic EES in the treatment of a de novo coronary artery stenosis. Protocol-mandated intravascular ultrasound imaging was performed pre-and post-procedure in 470 patients (162 metallic EES and 308 BVS). Asymmetry index (AI) was calculated per lesion as: (1 - minimum scaffold/stent diameter/maximum scaffold/stent diameter). Expansion index and optimal scaffold/ stent expansion followed the definition of the MUSIC (Multicenter Ultrasound Stenting in Coronaries) study. Eccentricity index (EI) was calculated as the ratio of minimum and maximum scaffold/stent diameter per cross section. The incidence of device-oriented composite endpoint (DoCE) was collected. RESULTS Post-procedure, the metallic EES group was more symmetric and concentric than the BVS group. Only 8.0% of the BVS arm and 20.0% of the metallic EES arm achieved optimal scaffold/stent expansion (p < 0.001). At 1 year, there was no difference in the DoCE between both devices (BVS 5.2% vs. EES 3.1%; p = 0.29). Post-procedural devices asymmetry and eccentricity were related to higher event rates while there was no relevance to the expansion status. Subsequent multivariate analysis identified that post-procedural AI > 0.30 is an independent predictor of DoCE (hazard ratio: 3.43; 95% confidence interval: 1.08 to 10.92; p = 0.037). CONCLUSIONS BVS implantation is more frequently associated with post-procedural asymmetric and eccentric morphology compared to metallic EES. Post-procedural devices asymmetry were independently associated with DoCE following percutaneous coronary intervention. However, this approach should be viewed as hypothesis generating due to low event rates. (C) 2016 by the American College of Cardiology Foundation.
引用
收藏
页码:1231 / 1242
页数:12
相关论文
共 27 条
[1]   Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: Insights from the ABSORB and SPIRIT trials [J].
Brugaletta, Salvatore ;
Gomez-Lara, Josep ;
Diletti, Roberto ;
Farooq, Vasim ;
van Geuns, Robert Jan ;
de Bruyne, Bernard ;
Dudek, Dariusz ;
Garcia-Garcia, Hector M. ;
Ormiston, John A. ;
Serruys, Patrick W. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) :219-228
[2]   A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: The AVIO trial [J].
Chieffo, Alaide ;
Latib, Azeem ;
Caussin, Christophe ;
Presbitero, Patrizia ;
Galli, Stefano ;
Menozzi, Alberto ;
Varbella, Ferdinando ;
Mauri, Fina ;
Valgimigli, Marco ;
Arampatzis, Chourmouzios ;
Sabate, Manuel ;
Erglis, Andrejs ;
Reimers, Bernhard ;
Airoldi, Flavio ;
Laine, Mika ;
Lopez Palop, Ramon ;
Mikhail, Ghada ;
MacCarthy, Philip ;
Romeo, Francesco ;
Colombo, Antonio .
AMERICAN HEART JOURNAL, 2013, 165 (01) :65-72
[3]   Impact of Intravascular Ultrasound Imaging on Early and Late Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stents [J].
Claessen, Bimmer E. ;
Mehran, Roxana ;
Mintz, Gary S. ;
Weisz, Giora ;
Leon, Martin B. ;
Dogan, Ozgen ;
Costa, Jose de Ribamar, Jr. ;
Stone, Gregg W. ;
Apostolidou, Irene ;
Morales, Andy ;
Chantziara, Vasiliki ;
Syros, George ;
Sanidas, Elias ;
Xu, Ke ;
Tijssen, Jan G. P. ;
Henriques, Jose P. S. ;
Piek, Jan J. ;
Moses, Jeffrey W. ;
Maehara, Akiko ;
Dangas, George D. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (09) :974-981
[4]   Intravascular ultrasound-guided optimized stent deployment - Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study) [J].
de Jaegere, P ;
Mudra, H ;
Figulla, H ;
Almagor, Y ;
Doucet, S ;
Penn, I ;
Colombo, A ;
Hamm, C ;
Bartorelli, A ;
Rothman, M ;
Nobuyoshi, M ;
Yamaguchi, T ;
Voudris, V ;
DiMario, C ;
Makovski, S ;
Hausmann, D ;
Rowe, S ;
Rabinovich, S ;
Sunamura, M ;
van Es, GA .
EUROPEAN HEART JOURNAL, 1998, 19 (08) :1214-1223
[5]   ABSORB II randomized controlled trial. A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design [J].
Diletti, Roberto ;
Serruys, Patrick W. ;
Farooq, Vasim ;
Sudhir, Krishnankutty ;
Dorange, Cecile ;
Miquel-Hebert, Karine ;
Veldhof, Susan ;
Rapoza, Richard ;
Onuma, Yoshinobu ;
Garcia-Garcia, Hector M. ;
Chevalier, Bernard .
AMERICAN HEART JOURNAL, 2012, 164 (05) :654-663
[6]   Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease [J].
Ellis, Stephen G. ;
Kereiakes, Dean J. ;
Metzger, D. Christopher ;
Caputo, Ronald P. ;
Rizik, David G. ;
Teirstein, Paul S. ;
Litt, Marc R. ;
Kini, Annapoorna ;
Kabour, Ameer ;
Marx, Steven O. ;
Popma, Jeffrey J. ;
McGreevy, Robert ;
Zhang, Zhen ;
Simonton, Charles ;
Stone, Gregg W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (20) :1905-1915
[7]   Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold: A Sub-Study of the ABSORB Cohort B and the On-Going ABSORB EXTEND Single Arm Study [J].
Farooq, Vasim ;
Gomez-Lara, Josep ;
Brugaletta, Salvatore ;
Gogas, Bill D. ;
Garcia-Garcia, Hector M. ;
Onuma, Yoshinobu ;
van Geuns, Robert Jan ;
Bartorelli, Antonio ;
Whitbourn, Robert ;
Abizaid, Alexandre ;
Serruys, Patrick W. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (06) :880-888
[8]   Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study [J].
Gomez-Lara, Josep ;
Diletti, Roberto ;
Brugaletta, Salvatore ;
Onuma, Yoshinobu ;
Farooq, Vasim ;
Thuesen, Leif ;
McClean, Dougal ;
Koolen, Jacques ;
Ormiston, John A. ;
Windecker, Stefan ;
Whitbourn, Robert ;
Dudek, Dariusz ;
Dorange, Cecile ;
Veldhof, Susan ;
Rapoza, Richard ;
Regar, Evelyn ;
Garcia-Garcia, Hector M. ;
Serruys, Patrick W. .
EUROINTERVENTION, 2012, 8 (02) :214-224
[9]   Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation The IVUS-XPL Randomized Clinical Trial [J].
Hong, Sung-Jin ;
Kim, Byeong-Keuk ;
Shin, Dong-Ho ;
Nam, Chung-Mo ;
Kim, Jung-Sun ;
Ko, Young-Guk ;
Choi, Donghoon ;
Kang, Tae-Soo ;
Kang, Woong-Chol ;
Her, Ae-Young ;
Kim, Yonghoon ;
Hur, Seung-Ho ;
Hong, Bum-Kee ;
Kwon, Hyuckmoon ;
Jang, Yangsoo ;
Hong, Myeong-Ki .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (20) :2155-2163
[10]   Physiological transport forces govern drug distribution for stent-based delivery [J].
Hwang, CW ;
Wu, D ;
Edelman, ER .
CIRCULATION, 2001, 104 (05) :600-605